Next Article in Journal
Impact of a Medical–Government Conflict on Healthcare Workers’ Mental Health in a Single Tertiary Hospital
Previous Article in Journal
Systemic Vascular Calcification After Lung Transplantation: The Role of Mammographic Breast Arterial Calcifications
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Rare Localization of Extramammary Paget’s Disease in the Axilla: A Case Report and Literature Review

by
Vera Smolyannikova
1,2,
Marina Krot
1,
Andrey Filatov
1,
Alina Mordovina
1,
Maria Kharitonova
2,
Olga Gafurova
1,
Valentina Kudryashova
1,
Yulia Lutokhina
3,
Sergey Pirozhkov
4 and
Marina Vukolova
4,*
1
Institute for Clinical Morphology and Digital Pathology, Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
2
FGBU State Scientific Center for Dermatovenereology, Cosmetology Clinical Diagnostic Center of the Ministry of Health of the Russian Federation, 107076 Moscow, Russia
3
V.N. Vinogradov Faculty Therapeutic Clinic, Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
4
Department of Pathological Physiology, Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(23), 8581; https://doi.org/10.3390/jcm14238581 (registering DOI)
Submission received: 18 October 2025 / Revised: 21 November 2025 / Accepted: 24 November 2025 / Published: 3 December 2025
(This article belongs to the Section Dermatology)

Abstract

Extramammary Paget’s disease is a rare malignant tumor that frequently presents in areas rich in apocrine glands, most often affecting the skin of the perianal area: the labia minora, clitoris, scrotum, penis, skin of the lower abdomen, and inguinal folds. Tumors localized outside the perianal region are relatively rare. We present a clinical case of a 70-year-old patient with a tumor localized on the skin of the right axillary region, with clinical, histological, and immunohistochemical characteristics. The diagnosis of extramammary Paget’s disease with atypical localization is relatively difficult to reach in time, as tumors are often mistakenly considered as inflammatory skin lesions, and the appropriate treatment may therefore be delayed.

1. Introduction

Extramammary Paget’s disease (EMPD) is a rare malignant tumor first described by G.R. Crocker in 1889 [1]. EMBP often presents in areas rich in apocrine glands, and most often affects the skin of the perianal area: the labia minora, clitoris, scrotum, penis, skin of the lower abdomen, and inguinal folds. Tumors localized outside the perianal region are relatively rare. The literature describes isolated cases of Paget’s disease of the axilla [2], eyelid [3], and ear canal [4]. EMPD may be divided into primary and secondary form; the primary form affects only the skin, while the secondary form comprises the intraepithelial spread of perianal malignancies (adenocarcinomas of the bladder, prostate, and lower gastrointestinal tract).
Data on the incidence of EMPD localized in the perianal region are quite contradictory, ranging from 0.1 to 2.4 per 1,000,000 people [5,6]. This makes up about 1 percent of all tumors with this localization. EMPD is most commonly diagnosed between ages 50 and 80 [7,8], and depending on the site of growth, the peak incidence falls within different age groups. Thus, EMPD of the vulva is most often observed at the age of 50–64 years, while EMPD of the scrotum usually occurs after 70 years of age [9]. EMPD in European women most commonly affects the vulva [10]. Interestingly, the incidence ratio in men and women in Asia is almost 1:1, which may be due to genetic differences compared with the Caucasian population [10].
Only 24 cases of extramammary Paget’s disease of the axilla have been reported in the literature. EMPD of the axilla was diagnosed in patients aged from 40 to 89 years, and included bilateral localization [2,11]. It is noteworthy that in several clinical cases, the occurrence of EMPD of the axilla was combined with sweat gland carcinoma [12,13] and squamous cell skin cancer [14].
Clinically, EMPD often manifests as a slowly enlarging, asymmetrical, red-white scaly plaque that may be painful and itchy [15]. Subsequently, these areas may become erosive, weeping, and crusty. In rare cases, extramammary Paget’s disease manifests as vesicles, vegetative lesions, or regional lymphadenopathy [16]. Itching is the most common symptom; other complaints include burning, irritation and a pain sensation, increased sensitivity, bleeding, or swelling. About 10% of EMPD cases are asymptomatic [17]. Often, EMPD is initially diagnosed as an inflammatory or infectious pathology due to its non-specific clinical signs.
A retrospective study of 246 cases of EMPD in a Chinese male population conducted in 2015 showed a significant time interval between the first manifestations and the final diagnosis in almost all patients, with a mean time of 43.2 months [18]. Interestingly, in one case, it took 30 years to establish a correct diagnosis. In a similar Japanese study that reported the analysis of 145 cases over a time span of 17 years, the mean delay in establishing an accurate diagnosis was 39.7 months [19,20,21,22].
Table 1 presents data about the incidence of EMPD in several countries.
Morphologically, EMPD is characterized by the intraepidermal proliferation of Paget’s cells. There are two main types of Paget’s cells based on their histology: type A, the classical type with porous nuclei, a large number of nucleoli, and pale cytoplasm, and type B, characterized by signet ring cells with a centrally located nucleus and huge droplets of mucin in the cytoplasm [34]. Paget’s cells are mainly located in the lower layers of the epidermis, but single cells are also found at higher levels, such as in the epithelial membranes of hair follicles, excretory ducts of the sebaceous glands, and the secretory part of sweat glands [35]. Large accumulations of Paget’s cells can be found in skin appendages, especially in tangential sections that can sometimes become misinterpreted as invasive tumor growth [36]. The epidermis is usually hyperplastic and displays deep, submerged growths [37]. Suprabasal intraepidermal acantholytic lesions may occasionally be found, and this feature may contribute to the misdiagnosis of EMPD as Darier disease or pemphigus [35]. In addition to traditional microscopy, histochemical methods are also widely used for to establish a proper diagnosis, particularly the PAS reaction for mucin in Paget’s cells. Immunohistochemistry is operational for differentiation between the primary and secondary forms of EMPD, as well as EMPD and various skin tumors [38,39,40,41,42]. Primary EMPD, also known as cutaneous or ectodermal EMPD, is characterized by the expression of sweat gland markers CK7+/CK20-/GCDFP-15+, while secondary EMPD has an endodermal phenotype and is associated with concomitant (primary) carcinoma, most often colorectal (CK7-/CK20+/GCDFP-15-) or urothelial (CK7+/CK20+/GCDFP-15-) [43].

2. Methodology

This report includes a description of a clinical case and a review of the literature. The patient selected for studies filled out and signed the informed consent form (ICF). This study was conducted in adherence to the Declaration of Helsinki.

2.1. The Review of Literature

The review of the literature was performed using a single database (PubMed) covering the period up to 2025, with no restrictions based on date of publication. The strategy for the literature search and criteria for selection relied on a series of keywords. The following descriptors were used: extramammary Paget’s disease, axilla, histology, tumor, erythema, inflammation, and immunohistochemistry. The authors of this report evaluated the included articles found in the search according to their title and summary and picked out those that fit the inclusion criteria for the study. With a focus on the last 10 years, a pool of reviewed studies was formed, including original articles, reviews, and epidemiological studies. When the reports were scarce on some topics, we also considered earlier publications.

2.2. Morphology and Immunohistochemistry

A biopsy of the skin from the edge of the tumor lesion was performed under local anesthesia using a 2% solution of lidocaine hydrochloride. Specimens were fixed in 10% neutral formalin. Formalin-fixed and paraffin-embedded tissue blocks were treated according to the standard procedure. Blocks were used to prepare histological sections stained with H&E. Immunohistochemical studies were performed with the use of the streptavidin–biotin–peroxidase method according to the standard scheme with 5 micron thick sections which were treated using primary monoclonal murine anti-CK7 antibodies (PBM-12F1 clone, Cell Marque, Rocklin, CA, USA). Positive and negative controls were applied in each case with the tissue samples recommended by the manufacturer. The results were evaluated with a light microscope, Leica DM4000B (100×, 200×, 400×). An E3ISPM camera (Suzhou, China) was used for photo fixation.

3. Case Report

A 70-year-old male patient attended the consultation department of the State Scientific Center for Dermatovenereology and the Cosmetology Clinical Diagnostic Center of the Ministry of Health of the Russian Federation, Moscow, Russia, with complaints of itching and discomfort in the right axillary region. According to his medical history, these symptoms first manifested 15 years ago. The patient noticed redness and maceration of the skin in the axillary area but could not associate it with any specific reason. His primary diagnosis after the first consulting with a dermatologist was “erythematous diaper rash”. The repeated external therapy and courses of antimycotics had no significant effect. Subsequently, the area of the lesion started to enlarge. At the time of examination, the whole skin surface of the right axilla was affected by erythema, which had also extended to adjacent areas. The erythema had clear boundaries, an irregular shape, areas of superficial maceration, and serous dull yellow exudate with a white coating. It was accompanied by an itching sensation (Figure 1). Diagnostic searches included Hailey–Hailey pemphigus, an exudative form of psoriasis, mycosis of large folds, intertriginous dermatitis with the addition of a secondary infection, and pyoderma. A biopsy was performed to clarify the diagnosis.
During histological examination, superficial layers of the epidermis were erosive (Figure 2a); the basal and lower layers of the stratum spinosum were replaced by large light cells without intercellular bridges (Figure 2b) spreading along the excretory ducts of sweat glands and hair follicles. In the dermis, there was a moderate lymphocytic infiltrate along the lower border of epidermis (Figure 2c). EMPD was diagnosed on the basis of morphological examination. An immunohistochemical (IHC) study was performed in order to confirm the histogenesis of the tumor using an automatic Bond immunostainer with the antibodies CK7, CK20, p63, and SOX10 on serial sections from the paraffin block using control sections to assess the reaction. Diffuse membrane–cytoplasmic expression of CK7 (Figure 2d) was noted in 100% of tumor cells; the reaction with CK20, p63, and SOX10 was negative. Based on the histological and immunohistochemical studies, a diagnosis of extramammary Paget’s disease was confirmed.
The patient was referred to the cancer center, where the diagnosis of extramammary Paget’s disease was confirmed. Further examination, which included an X-ray of the thoracic cavity and a CT scan with contrasting, revealed the axillary lymph nodes’ involvement in the affected side. Given the size of the skin lesion, it was decided to withdraw from surgical manipulations and to offer radiation therapy to the patient. However, the patient refused to undergo any further treatment.

4. Discussion

Extramammary Paget’s disease (EMPD) is a rare malignant tumor that affects the epithelium of apocrine glands. EMPD pathogenesis is still unknown. Based on genomic analysis, somatic mutations have been identified in several genes, including TP53, ERBB, NRAS, BRAF, PIK3CA, and AKT1 [44]. It has been speculated that HER2 encoded by ERBB2 and its signaling pathways, including RAS/RAF-MEK-ERK and PI3K-AKT-mTOR, may play a role in EMPD pathogenesis [45]. In addition, evidence has been obtained that hormonal status may also contribute to the pathogenesis of EMPD. In particular, the increased expression of FOXA1 in Paget cells, noted in some patients with EMPD, has been found to correlate with the expression of estrogen receptors (ER) [46]. Given the fact that FOXA1 supports ER transcriptional activity and that both of these transcription factors may be involved in breast carcinogenesis, FOXA1-ER cooperation may serve as a boosting factor in the development and progression of EMPD [47]. In addition, IHC studies have demonstrated the overexpression of transmembrane prolactin receptor (PRLR) [48,49] and the high expression of androgen receptors (AR), reaching levels of 54–90%. It is remarkable that the age of EMPD manifestation in their studies, as in our report, mostly exceeded 50 years, suggesting the role of dyshormonal disorders as a putative link in the mechanisms of this pathology [50,51,52].
Based on the analysis of the published clinical cases and reports, we have come to the conclusion that the axillary form of EMPD is rare and, as in our case, presents complexities in obtaining the correct diagnosis due to its unusual localization and blurred clinical manifestations. Typically, patients are observed for a long time, with diagnoses varying from eczema to diaper rash, superficial pyoderma, pemphigus, etc. In the reported case, the patient was treated for erythematous diaper rash for 15 years, while the pathological alterations continued to progress. In all cases of the suspected EMPD, its diagnosis can be confirmed only by histological examination. In our observation, the classic form of EMPD was established by a characteristic picture of proliferation of the large light pagetoid cells replacing all layers of the epidermis. The inability of the Paget cells to form intercellular bridges often leads to erosion of the tumor surface, cracks, and blisters, which can be erroneously interpreted as pemphigus, eczema, superficial pyoderma, mycoses, and their variations.
According to the latest recommendations of 2022, the choice of therapy for widespread extramammary Paget’s disease is based on the molecular profile of the tumor and on the presence or absence of metastases [53]. The main direction in the therapy of this disease includes surgical treatment with widespread excision of the tumor. Currently, it is been debated whether there is a need for a 2 to 5 cm indent from the cut-off edges of the tumor, given the possibility of its multicentric growth [54,55]. At the same time, it has been shown in a series of studies that a 1 or 2 cm indent would prove to be sufficient [56]. In cases with a small volume of skin lesions, Mohs micrographic surgery (MMS) may be used.
When surgical removal of the tumor is not recommended, the patient may be suitable for radiation therapy or may be treated via the local application of Imiquimod cream (IMQ) and photodynamic therapy (PDT). The efficiency of radiation therapy and the relapse-free period after treatment are comparable to the results of surgical excision [57,58].
Imiquimod cream (IMQ) is a synthetic ligand of the Toll-like receptor 7 which has been proved to exert an anticancer effect. IMQ efficiency has been demonstrated in therapy of basal cell carcinoma and actinic keratosis. At the same time, monotherapy of extramammary Paget’s disease by IMQ is under debate due to a high proportion of relapses [59]. Treatment of extramammary Paget’s disease by PDT also exhibits moderate efficiency, since it fails to achieve a complete response of the tumor [60,61].

5. Conclusions

Our case of extramammary Paget’s disease of the axilla highlights the common difficulties in its diagnosis. It is often misdiagnosed for a long time as an inflammatory skin disease, leading to a significant delay in treatment. Therefore, biopsy is crucial in all patients with eczema and inflammatory skin diseases with an atypical course of pathology manifesting as a large accumulation of apocrine glands and exhibiting no response to treatment within 4–6 weeks. When examining biopsy material, the diagnostic immunohistochemical panel for EMPD is CK7-positive, CK20-positive or -negative, p63-negative, and SOX10-negative [26]. Overexpression of ERBB2 (HER2) [62,63,64] and protein kinase B [65,66,67,68,69,70] may be associated with the invasive forms of EMPD and metastases to lymph nodes [71].

Author Contributions

Conceptualization, V.S., M.K. (Marina Krot) and M.K. (Maria Kharitonova); formal analysis, V.K., A.F. and M.K. (Marina Krot); validation, V.S. and A.F.; writing—original draft preparation, O.G. and A.M.; writing—review and editing, M.V., S.P. and Y.L.; project administration, M.V. and S.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Review or approval by an ethics committee was not needed for this case report, because data were gathered retrospectively and the case highlights a rare manifestation of the disease. This case report does not present new investigation tactics or treatment methods. All patient-identifying information was excluded from the manuscript.

Informed Consent Statement

Written informed consent has been obtained from the patient to publish this paper.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors have no conflicts of interest to declare.

Abbreviations

The following abbreviations are used in this manuscript:
ARAndrogen receptors
EMPDExtramammary Paget’s disease
EREstrogen receptors
ICFInformed consent form
IHCImmunohistochemical
PRLRTransmembrane prolactin receptor

References

  1. Crocker, H. Paget’s disease affecting the scrotum and penis. Trans. Pathol. Soc. Lond. 1889, 40, 187–191. [Google Scholar]
  2. Zhao, C.; Li, Y.; Zhang, C.; Zhang, G.; Li, H. Extramammary Paget’s disease involving the axilla: Case series and literature review. Int. J. Dermatol. 2023, 62, 933–937. [Google Scholar] [CrossRef] [PubMed]
  3. Chan, J.Y.; Li, G.K.; Chung, J.H.; Chow, V.L. Extramammary Paget’s Disease: 20 Years of Experience in Chinese Population. Int. J. Surg. Oncol. 2012, 2012, 416418. [Google Scholar] [CrossRef] [PubMed]
  4. Nagarajan, P. Ceruminous Neoplasms of the Ear. Head Neck Pathol. 2018, 12, 350–361. [Google Scholar] [CrossRef]
  5. Siesling, S.; Elferink, M.A.; van Dijck, J.A.; Pierie, J.P.; Blokx, W.A. Epidemiology and treatment of extramammary Paget disease in the Netherlands. Eur. J. Surg. Oncol. 2007, 33, 951–955. [Google Scholar] [CrossRef]
  6. Pérez, J.C.; Salgado, A.C.; Pérez-Mies, B.; Rullán, J.A.D.; Ajuria-Illarramendi, O.; Alia, E.M.G.; Serrano Domingo, J.J. Extramammary Paget Disease: A Therapeutic Challenge, for a Rare Entity. Curr. Oncol. Rep. 2023, 25, 1081–1094. [Google Scholar] [CrossRef]
  7. Fan, L.; Zhu, J.; Tao, X.; Xu, C. Intraepithelial extramammary Paget’s disease of the vulva: The clinicopathological characteristics, management, and outcome in a study of 18 female patients. Dermatol. Surg. 2016, 42, 1142–1146. [Google Scholar] [CrossRef]
  8. Cho, A.; Kim, D.Y.; Suh, D.S.; Kim, J.H.; Kim, Y.M.; Kim, Y.T.; Park, J.Y. Outcomes and prognostic factors of surgically treated extramammary Paget’s disease of the vulva. J. Gynecol. Oncol. 2023, 34, e76. [Google Scholar] [CrossRef]
  9. Zollo, J.D.; Zeitouni, N.C. The roswell park cancer institute experience with extramammary paget’s disease. Br. J. Dermatol. 2000, 142, 59–65. [Google Scholar] [CrossRef]
  10. Hirata, Y.; Aoyagi, S.; Mizuno, O.; Homma, E.; Hata, H.; Shimizu, H. Bilateral axillary Paget’s disease: Diagnostic pitfalls of dermoscopic features. Int. J. Dermatol. 2014, 53, e126–e127. [Google Scholar] [CrossRef]
  11. Wu, J.; Chen, H.; Dong, J.; Cao, Y.; Li, W.; Zhang, F.; Zeng, X. Axillary masses as clinical manifestations of male sweat gland carcinoma associated with extramammary Paget’s disease and accessory breast carcinoma: Two cases report and literature review. World J. Surg. Oncol. 2022, 20, 109. [Google Scholar] [CrossRef]
  12. Miyamoto, T.; Adachi, K.; Fujishima, M. Axillary apocrine carcinoma with Paget’s disease and apocrine naevus. Clin. Exp. Dermatol. 2009, 34, e110–e113. [Google Scholar] [CrossRef]
  13. Goto, H.; Adachi, K.; Yamada, N.; Shiomi, T.; Kiyohara, Y.; Yoshida, Y.; Yamamoto, O. Concurrent occurrence of axillary extramammary Paget’s disease and squamous cell carcinoma. Eur. J. Dermatol. 2016, 26, 202–204. [Google Scholar] [CrossRef] [PubMed]
  14. Lee, S.J.; Choe, Y.S.; Jung, H.D.; Ahn, S.K.; Cha, Y.C.; Cho, K.H.; Choi, H.Y.; Chung, K.Y.; Huh, C.H.; Kim, I.H.; et al. Korean Society for Skin Cancer and Korean Dermatopathology Research Group. A multicenter study on extramammary Paget’s disease in Korea. Int. J. Dermatol. 2011, 50, 508–515. [Google Scholar] [CrossRef] [PubMed]
  15. Funaro, D.; Krasny, M.; Lam, C.; Desy, D.; Sauthier, P.; Bouffard, D. Extramammary Paget disease: Epidemiology and association to cancer in a Quebec-based population. J. Low Genit. Tract. Dis. 2013, 17, 167–174. [Google Scholar] [CrossRef] [PubMed]
  16. Ueda, M.; Omori, M.; Sakai, A. Invasive extramammary Paget’s disease with lymph node metastases and high-grade B-cell lymphoma. An. Bras. Dermatol. 2023, 98, 414–418. [Google Scholar] [CrossRef]
  17. Lloyd, J.; Flanagan, A.M. Mammary and extramammary Paget’s disease. J. Clin. Pathol. 2000, 53, 742–749. [Google Scholar] [CrossRef]
  18. Ito, T.; Kaku, Y.; Nagae, K.; Nakano-Nakamura, M.; Nakahara, T.; Oda, Y.; Hagihara, A.; Furue, M.; Uchi, H. Tumor thickness as a prognostic factor in extramammary Paget’s disease. J. Dermatol. 2015, 42, 269–275. [Google Scholar] [CrossRef]
  19. Kiniwa, Y.; Yasuda, J.; Saito, S.; Saito, R.; Motoike, I.N.; Danjoh, I.; Kinoshita, K.; Fuse, N.; Yamamoto, M.; Okuyama, R. Identification of genetic alterations in extramammary Paget disease using whole exome analysis. J. Dermatol. Sci. 2019, 94, 229–235. [Google Scholar] [CrossRef]
  20. Cheng, P.S.; Lu, C.L.; Cheng, C.L.; Lai, F.J. Significant male predisposition in extramammary Paget disease: A nationwide population-based study in Taiwan. Br. J. Dermatol. 2014, 171, 191–193. [Google Scholar] [CrossRef]
  21. Wolf, K.; Stewart, L.; Rapini, R.; Mutyambizi, K. Multifocal extramammary Paget’s disease-associated adenocarcinoma: A rare condition of flexoral skin of multiple sites. Dermatol. Online J. 2016, 22, 13030/qt8bp3138w. [Google Scholar] [CrossRef]
  22. Mun, J.H.; Park, S.M.; Kim, G.W.; Song, M.; Kim, H.S.; Ko, H.C.; Kim, B.S.; Kim, M.B. Clinical and dermoscopic characteristics of extramammary Paget disease: A study of 35 cases. Br. J. Dermatol. 2016, 174, 1104–1107. [Google Scholar] [CrossRef] [PubMed]
  23. Ji, W.Y.; Luo, B.; Wang, X.W.; Xiao, Y.; Tian, J.Y. Axillary Paget disease with a visible satellite: A case report and literature review. Diagn. Pathol. 2021, 16, 69. [Google Scholar] [CrossRef] [PubMed]
  24. Zhou, Z.; Zhou, B.; Wu, X.; Wei, W. Case report: A case of Paget disease outside the axillary breast. Medicine 2024, 103, e37541. [Google Scholar] [CrossRef] [PubMed]
  25. Zhao, C.; Zhang, G.; Li, Y.; Zhang, C.; Yang, S.; Li, H. Concurrent extramammary Paget’s disease involving the genitalia and axilla: Case report and literature review. Australas. J. Dermatol. 2022, 63, e226–e230. [Google Scholar] [CrossRef]
  26. Chuchvara, N.; Reilly, C.; Haroon, A.; Wassef, C.; Maghari, A.; Rao, B. Atypical cells on reflectance confocal microscopy may not represent melanoma: A case of axillary pigmented extramammary Paget disease. J. Cutan. Pathol. 2020, 47, 1170–1174. [Google Scholar] [CrossRef]
  27. Dai, C.; Baird, B.A.; Lyon, T.D.; Sokumbi, O.; Degesys, C.A. Extramammary Paget disease of the axilla and scrotum in a Caucasian man. JAAD Case Rep. 2022, 22, 87–89. [Google Scholar] [CrossRef]
  28. Felts, C.; Durkin, V.; Kerkvliet, A. A Rare Case of Axillary Extramammary Paget’s Disease with an Underlying Adenocarcinoma. South Dak. Med. 2024, 77, 152–156. [Google Scholar]
  29. Kimura, R.; Yoshida, Y.; Shiomi, T.; Yanagihara, S.; Tsutsumi, R.; Sugita, K.; Yamamoto, O. Multiorgan involvement of extramammary Paget’s disease with mucinous carcinoma-like components. Eur. J. Dermatol. 2016, 26, 615–617. [Google Scholar] [CrossRef]
  30. Imai, S.; Nitto, H.; Imai, R. Axillary Paget’s disease. J. Dermatol. 1981, 8, 245–252. [Google Scholar] [CrossRef]
  31. Miyamoto, T.; Hagari, Y.; Inoue, S.; Watanabe, T.; Yoshino, T. Axillary apocrine carcinoma with benign apocrine tumours: A case report involving a pathological and immunohistochemical study and review of the literature. J. Clin. Pathol. 2005, 58, 757–761. [Google Scholar] [CrossRef]
  32. Scalvenzi, M.; Cappello, M.; Russo, D.; Mascolo, M.; Monfrecola, G.; Costa, C. Double extramammary Paget’s disease. G. Ital. Dermatol. Venereol. 2018, 153, 126–127. [Google Scholar] [CrossRef] [PubMed]
  33. Jang, S.B.; Kim, S.E.; Kim, Y.A.; Choi, H.R. Co-occurrence of apocrine adenocarcinoma and invasive mammary-type ductal carcinoma in extramammary Paget disease of the axilla. Arch. Plast Surg. 2020, 47, 83–87. [Google Scholar] [CrossRef] [PubMed]
  34. Hirai, I.; Tanese, K.; Nakamura, Y.; Otsuka, A.; Fujisawa, Y.; Yamamoto, Y.; Hata, H.; Fujimura, T.; Matsushita, S.; Yoshino, K.; et al. Assessment of the methods used to detect HER2-positive advanced extramammary Paget’s disease. Med. Oncol. 2018, 9, 92. [Google Scholar] [CrossRef] [PubMed]
  35. Lee, G.C.; Kunitake, H.; Stafford, C.; Bordeianou, L.G.; Francone, T.D.; Ricciardi, R. High Risk of Proximal and Local Neoplasms in 2206 Patients with Anogenital Extramammary Paget’s Disease. Dis. Colon. Rectum. 2019, 62, 1283–1293. [Google Scholar] [CrossRef]
  36. Lam, C.; Funaro, D. Extramammary Paget’s disease: Summary of current knowledge. Dermatol. Clin. 2010, 28, 807–826. [Google Scholar] [CrossRef]
  37. Smith, A.A. Pre-Paget cells: Evidence of keratinocyte origin of extramammary Paget’s disease. Intractable Rare Dis. Res. 2019, 8, 203–205. [Google Scholar] [CrossRef]
  38. Willman, J.H.; Golitz, L.E.; Fitzpatrick, J.E. Vulvar clear cells of Toker: Precursors of extramammary Paget’s disease. Am. J Dermatopathol. 2005, 27, 185–188. [Google Scholar] [CrossRef]
  39. Baker, G.M.; Bret-Mounet, V.C.; Xu, J.; Fein-Zachary, V.J.; Tobias, A.M.; Bartlett, R.A.; Clohessy, J.G.; Vlachos, I.S.; Massicott, E.S.; Wulf, G.M.; et al. Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine Individuals. Mod. Pathol. 2023, 36, 100121. [Google Scholar] [CrossRef]
  40. Wong, J.; Pina, A.; Mayrand, M.H.; Rahimi, K. Pagetoid Squamous Intraepithelial Neoplasia of the Vulva as a Mimicker of Vulvar Extramammary Paget Disease: Two Cases with Basal Layer Sparing. Int. J. Surg. Pathol. 2023, 31, 1302–1307. [Google Scholar] [CrossRef]
  41. Kibbi, N.; Owen, J.L.; Worley, B.; Wang, J.X.; Harikumar, V.; Downing, M.B.; Aasi, S.Z.; Aung, P.P.; Barker, C.A.; Bolotin, D.; et al. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. JAMA Oncol. 2022, 8, 618–628. [Google Scholar] [CrossRef]
  42. Nabavizadeh, R.; Vashi, K.B.; Nabavizadeh, B.; Narayan, V.M.; Master, V.A. Extramammary Paget’s disease: Updates in the workup and management. Asian J. Urol. 2022, 9, 451–459. [Google Scholar] [CrossRef] [PubMed]
  43. Ohnishi, T.; Watanabe, S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget’s disease. Br. J. Dermatol. 2000, 142, 243–247. [Google Scholar] [CrossRef] [PubMed]
  44. Ishida, Y.; Kakiuchi, N.; Yoshida, K.; Inoue, Y.; Irie, H.; Kataoka, T.R.; Hirata, M.; Funakoshi, T.; Matsushita, S.; Hata, H.; et al. Unbiased Detection of Driver Mutations in Extramammary Paget Disease. Clin. Cancer Res. 2021, 15, 1756–1765. [Google Scholar] [CrossRef] [PubMed]
  45. Bartoletti, M.; Mazzeo, R.; De Scordilli, M.; Del Fabro, A.; Vitale, M.G.; Bortot, L.; Nicoloso, M.S.; Corsetti, S.; Bonotto, M.; Scalone, S.; et al. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva. Int. J. Gynecol. Cancer 2020, 30, 1672–1677. [Google Scholar] [CrossRef]
  46. Zhang, Y.; Zhang, D.; Li, Q.; Liang, J.; Sun, L.; Yi, X.; Chen, Z.; Yan, R.; Xie, G.; Li, W.; et al. Nucleation of DNA repair factors by FOXA1 links DNA demethylation to transcriptional pioneering. Nat. Genet. 2016, 48, 1003–1013. [Google Scholar] [CrossRef]
  47. Lin, J.R.; Liang, J.; Zhang, Q.A.; Huang, Q.; Wang, S.S.; Qin, H.H.; Chen, L.J.; Xu, J.H. Microarray-based identification of differentially expressed genes in extramammary Paget’s disease. Int. J. Clin. Exp. Med. 2015, 15, 7251–7260. [Google Scholar]
  48. Clevenger, C.V.; Gadd, S.L.; Zheng, J. New mechanisms for PRLr action in breast cancer. Trends Endocrinol. Metab. 2009, 20, 223–229. [Google Scholar] [CrossRef]
  49. Scarbrough, C.A.; Vrable, A.; Carr, D.R. Definition, Association with Malignancy, Biologic Behavior, and Treatment of Ectopic Extramammary Paget’s Disease: A Review of the Literature. J. Clin. Aesthet Dermatol. 2019, 12, 40–44. [Google Scholar]
  50. Ren, F.; Zhao, S.; Yang, C.; Liu, J.; Shang, Q.; Feng, K.; Kang, X.; Zhang, R.; Wang, X.; Wang, X. Applications of photodynamic therapy in extramammary Paget’s disease. Am. J. Cancer Res. 2023, 13, 4492–4507. [Google Scholar]
  51. Chang, K.; Li, G.X.; Kong, Y.Y.; Shen, X.X.; Qu, Y.Y.; Jia, Z.W.; Wang, Y.; Dai, B.; Ye, D.W. Chemokine Receptors CXCR4 and CXCR7 are Associated with Tumor Aggressiveness and Prognosis in Extramammary Paget Disease. J. Cancer 2017, 8, 2471–2477. [Google Scholar] [CrossRef]
  52. Kibbi, N.; Owen, J.L.; Worley, B.; Wang, J.X.; Harikumar, V.; Aasi, S.Z.; Chandra, S.; Choi, J.N.; Fujisawa, Y.; Iavazzo, C.; et al. Anatomic Subtype Differences in Extramammary Paget Disease: A Meta-Analysis. JAMA Dermatol. 2024, 160, 417–424. [Google Scholar] [CrossRef]
  53. Ortuz Lessa, C.; Fernández Varela Gómez, F.; Garzón Ortega, V.H.; Sandoval García, A.; López Soto, K.; Brito Brito, N.R. Insights Into Mammary and Extramammary Paget’s Disease: Diagnosis, Management, and Recent Advances. Cureus. 2025, 17, e80531. [Google Scholar] [CrossRef]
  54. Chung, P.H.; Leong, J.Y.; Voelzke, B.B. Surgical Experience with Genital and Perineal Extramammary Paget’s Disease. Urology. 2019, 128, 90–95. [Google Scholar] [CrossRef]
  55. Hendi, A.; Brodland, D.G.; Zitelli, J.A. Extramammary Paget’s disease: Surgical treatment with Mohs micrographic surgery. J. Am. Acad. Dermatol. 2004, 51, 767–773. [Google Scholar] [CrossRef] [PubMed]
  56. Hatta, N.; Yamada, M.; Hirano, T.; Fujimoto, A.; Morita, R. Extramammary Paget’s disease: Treatment, prognostic factors and outcome in 76 patients. Br. J. Dermatol. 2008, 158, 313–318. [Google Scholar] [CrossRef] [PubMed]
  57. Hata, M.; Koike, I.; Wada, H.; Miyagi, E.; Kasuya, T.; Kaizu, H.; Matsui, T.; Mukai, Y.; Ito, E.; Inoue, T. Radiation therapy for extramammary Paget’s disease: Treatment outcomes and prognostic factors. Ann. Oncol. 2014, 25, 291–297. [Google Scholar] [CrossRef] [PubMed]
  58. Hata, M.; Koike, I.; Wada, H.; Miyagi, E.; Kasuya, T.; Kaizu, H.; Mukai, Y.; Inoue, T. Postoperative radiation therapy for extramammary Paget’s disease. Br. J. Dermatol. 2015, 172, 1014–1020. [Google Scholar] [CrossRef]
  59. Sawada, M.; Kato, J.; Yamashita, T.; Yoneta, A.; Hida, T.; Horimoto, K.; Sato, S.; Uhara, H. Imiquimod 5% cream as a therapeutic option for extramammary Paget’s disease. J. Dermatol. 2018, 45, 216–219. [Google Scholar] [CrossRef]
  60. Fontanelli, R.; Papadia, A.; Martinelli, F.; Lorusso, D.; Grijuela, B.; Merola, M.; Solima, E.; Ditto, A.; Raspagliesi, F. Photodynamic therapy with M-ALA as non-surgical treatment option in patients with primary extramammary Paget’s disease. Gynecol. Oncol. 2013, 130, 90–94. [Google Scholar] [CrossRef]
  61. Raspagliesi, F.; Fontanelli, R.; Rossi, G.; Ditto, A.; Solima, E.; Hanozet, F.; Kusamura, S. Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget’s disease of the vulva: A pilot study. Gynecol. Oncol. 2006, 103, 581–586. [Google Scholar] [CrossRef]
  62. Ishizuki, S.; Nakamura, Y. Extramammary Paget’s Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments. Curr. Oncol. 2021, 28, 2969–2986. [Google Scholar] [CrossRef]
  63. Phyo, A.K.; Mun, K.S.; Kwan, K.C.; Ann, C.C.; Kuppusamy, S. Genitourinary extramammary Paget’s disease: Review and outcome in a multidisciplinary setting. Int. J. Clin. Exp. Pathol. 2020, 13, 2369–2376. [Google Scholar] [PubMed]
  64. Hata, H.; Kitamura, S.; Inamura, Y.; Imafuku, K.; Homma, E.; Muramatsu, K.; Natsuga, K.; Abe, R.; Shimizu, H. mTOR expression correlates with invasiveness and progression of extramammary Paget’s disease. J. Eur. Acad. Dermatol. Venereol. 2016, 30, 1238–1239. [Google Scholar] [CrossRef] [PubMed]
  65. Chen, S.Y.; Takeuchi, S.; Moroi, Y.; Hayashida, S.; Kido, M.; Tomoeda, H.; Uenotsuchi, T.; Tu, Y.T.; Furue, M.; Urabe, K. Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget’s disease. J. Cutan. Pathol. 2009, 36, 402–408. [Google Scholar] [CrossRef] [PubMed]
  66. Kang, Z.; Xu, F.; Zhang, Q.A.; Lin, J.; Wu, Z.; Zhang, X.; Luo, Y.; Xu, J.; Guan, M. Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget’s disease. Mod. Pathol. 2012, 25, 1160–1168. [Google Scholar] [CrossRef]
  67. Kang, Z.; Xu, F.; Zhang, Q.A.; Wu, Z.; Zhang, X.; Xu, J.; Luo, Y.; Guan, M. Oncogenic mutations in extramammary Paget’s disease and their clinical relevance. Int. J. Cancer 2013, 132, 824–831. [Google Scholar] [CrossRef]
  68. Hatta, N. Prognostic Factors of Extramammary Paget’s Disease. Curr. Treat. Options Oncol. 2018, 19, 47. [Google Scholar] [CrossRef]
  69. Plaza, J.A.; Torres-Cabala, C.; Ivan, D.; Prieto, V.G. HER-2/neu expression in extramammary Paget disease: A clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy. J. Cutan. Pathol. 2009, 36, 729–733. [Google Scholar] [CrossRef]
  70. Smith, K.J.; Tuur, S.; Corvette, D.; Lupton, G.P.; Skelton, H.G. Cytokeratin 7 staining in mammary and extramammary Paget’s disease. Mod. Pathol. 1997, 10, 1069–1074. [Google Scholar]
  71. Matin, R.N.; Gibbon, K.; Rizvi, H.; Harwood, C.A.; Cerio, R. Cutaneous mucinous carcinoma arising in extramammary Paget disease of the perineum. Am. J. Dermatopathol. 2011, 33, 705–709. [Google Scholar] [CrossRef]
Figure 1. Irregular erythema with clear boundaries with an approximate size of 15 × 18 cm on the skin of the right axillary fold with the transition to the shoulder surface and the lateral surface of the trunk on the same side; there are areas of surface maceration and serous cloudy yellow exudate, occasionally covered with a white coating.
Figure 1. Irregular erythema with clear boundaries with an approximate size of 15 × 18 cm on the skin of the right axillary fold with the transition to the shoulder surface and the lateral surface of the trunk on the same side; there are areas of surface maceration and serous cloudy yellow exudate, occasionally covered with a white coating.
Jcm 14 08581 g001
Figure 2. (a) Tumor tissue of the epidermis with areas of erosion of the superficial sections throughout (100× magnification); (b) tumor cells in the lower layers of the epidermis and lymphohistiocytic infiltrate in the upper part of the dermis (200× magnification); (c) the tumor spreads along the excretory ducts of sweat glands and hair follicles (100× magnification); (d) diffuse membrane–cytoplasmic expression of CK7 in all tumor cells (100× magnification).
Figure 2. (a) Tumor tissue of the epidermis with areas of erosion of the superficial sections throughout (100× magnification); (b) tumor cells in the lower layers of the epidermis and lymphohistiocytic infiltrate in the upper part of the dermis (200× magnification); (c) the tumor spreads along the excretory ducts of sweat glands and hair follicles (100× magnification); (d) diffuse membrane–cytoplasmic expression of CK7 in all tumor cells (100× magnification).
Jcm 14 08581 g002
Table 1. Case reports of EMPD published in different countries over the past 5 years.
Table 1. Case reports of EMPD published in different countries over the past 5 years.
CountryIncidence (Number of Cases Reported in the Literature) References
China6 [11,23,24,25]
United States4 [26,27,28]
Japan4 [29,30,31]
Italy3 [32]
South Korea1 [33]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Smolyannikova, V.; Krot, M.; Filatov, A.; Mordovina, A.; Kharitonova, M.; Gafurova, O.; Kudryashova, V.; Lutokhina, Y.; Pirozhkov, S.; Vukolova, M. Rare Localization of Extramammary Paget’s Disease in the Axilla: A Case Report and Literature Review. J. Clin. Med. 2025, 14, 8581. https://doi.org/10.3390/jcm14238581

AMA Style

Smolyannikova V, Krot M, Filatov A, Mordovina A, Kharitonova M, Gafurova O, Kudryashova V, Lutokhina Y, Pirozhkov S, Vukolova M. Rare Localization of Extramammary Paget’s Disease in the Axilla: A Case Report and Literature Review. Journal of Clinical Medicine. 2025; 14(23):8581. https://doi.org/10.3390/jcm14238581

Chicago/Turabian Style

Smolyannikova, Vera, Marina Krot, Andrey Filatov, Alina Mordovina, Maria Kharitonova, Olga Gafurova, Valentina Kudryashova, Yulia Lutokhina, Sergey Pirozhkov, and Marina Vukolova. 2025. "Rare Localization of Extramammary Paget’s Disease in the Axilla: A Case Report and Literature Review" Journal of Clinical Medicine 14, no. 23: 8581. https://doi.org/10.3390/jcm14238581

APA Style

Smolyannikova, V., Krot, M., Filatov, A., Mordovina, A., Kharitonova, M., Gafurova, O., Kudryashova, V., Lutokhina, Y., Pirozhkov, S., & Vukolova, M. (2025). Rare Localization of Extramammary Paget’s Disease in the Axilla: A Case Report and Literature Review. Journal of Clinical Medicine, 14(23), 8581. https://doi.org/10.3390/jcm14238581

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop